• Cancer Screening

    Essentially, no cancer produces signs or symptoms at the outset. During this period, which varies considerably among cancer types, the only way to detect a cancer is through screening. Since the chances of curing many cancers increases the earlier it is diagnosed, physicians often recommend screening tests for the early detection of cancer or precancerous conditions well before symptoms develop. However, the results of screening tests are not definitive. They need to be confirmed or disproved with further testing.
    In order to be effective, a cancer screening program must at least meet the following criteria:
    • The cancer being screened must be common
    • There must be a long period of time during which the cancer is detectable in the absence of symptoms, and, ideally, the cancer must remain localized in the primary area during that time
    • The screening tests must be accurate, inexpensive, and acceptable to patients
    Because screening tests are almost never definitive in themselves, a second test is generally required to confirm (or exclude) the diagnosis of cancer. This follow up test should not be a repeat of the screening test, but should be a more "specific" test, meaning it's less likely to have false results than the screening test. Most confirmatory tests are tissue biopsies: a portion of the questionable tissue is taken and examined under the microscope to determine whether or not cancer is present.
    Unfortunately, all of these conditions are not always met. Consider breast and ovarian cancer.

    Breast Cancer Screening

    Routine mammograms (x-rays of the breast) are commonly recommended for women over 40 years of age. As a screening test, mammograms make sense because they detect an extremely common condition, are relatively inexpensive to perform, and are reasonably sensitive at finding tumors too small to be detected by either you or your doctor.
    However, mammograms are not specific. In fact, for a woman whose risk of breast cancer is low (those under age 50, for example, with no family history), a positive mammogram is very unlikely to be cancer. In other words, it is more likely than not a false positive result. It is for this reason that a mammogram, or any screening test for that matter, should never be relied upon to make the final diagnosis of cancer. A biopsy is always required and the utility of a mammogram is that it directs the biopsy to the proper spot.

    Ovarian Cancer Screening

    Unlike breast cancer, there is no effective screening test for ovarian cancer. Routine screening currently takes place during the gynecologic exam, which is not very sensitive at detecting small tumors. Another approach would be to perform an invasive procedure called a laparoscopy on essentially all women, which would be entirely impractical due to the expense and risk involved. Fortunately, ovarian cancer is relatively rare, especially when compared to breast cancer.
    It turns out that there are only a handful of cancers—breast, cervical, skin, prostate, colorectal—for which useful screening tests exist.

    Screening Schedules

    There is disagreement among medical groups regarding the appropriate timing and frequency for some of the screening tests.
    Below are recommendations for the American Cancer Society (ACS) for routine cancer screening in people at average risk (same as the general population) for cancer. Other organizations may have different recommendations. People at higher risk (those with a family history, for example) should generally be screened earlier and more frequently. Speak with your doctor about the appropriate screening schedule for you.
    Lung Cancer
    Not recommended on a routine basis (because of the frequency of false negative tests, even in carefully selected populations)
    Chest x-ray
    Sputum cytology
    Rectal and Colon cancer
    Fecal occult blood test
    Yearly after age 50
    Sigmoidoscopy with or without barium enema
    Every 5 years after age 50
    Double-contrast barium enema
    Every 5 years
    Every 10 years after age 50
    Prostate Cancer
    Discuss with doctor the blood test for prostate specific antigen with or without a digital rectal examination
    Yearly after age 50, Men at high risk should begin screening at 45
    Cervical, Uterine, and Ovarian Cancers
    Pelvic examination
    Every 1 to 3 years between the ages of 18 and 40, then yearly after age 40
    Cervical Cancer
    Pap test
    Every 3 years for ages 21-29
    Every 5 years for ages 30-65 if having both Pap test and the human papillomavirus (HPV) test (or continue to have the Pap test every 3 years)
    May be able to stop these screening tests at age 65
    Breast Cancer
    Breast self-examination
    Monthly after age 20
    Breast physical examination
    Every 3 years between ages 20 and 40, then yearly
    Yearly beginning at age 40; some protocols suggest every 1-2 years depending on the relative risk status of the patient

    Risks of Screening

    As with all things, the potential benefits of cancer screening must be weighed against the potential harms. False-positive results for example, can create undue psychologic stress, and if they occur often, can produce unacceptable numbers of unnecessary invasive, expensive and painful diagnostic tests. And even a true positive result may not always be in a patient’s best interest. Because of its slow growth, for example, prostate cancer may never have harmed an elderly man who was successfully screened with the prostate-specific antigen (PSA) blood test. But now that he has the information, he may feel compelled to undergo an aggressive course of treatment to remove the tumor.
    Screening tests can also produce false-negative results . This occurs when a screening test fails to detect cancer that is actually present. A false-negative screening test may mistakenly reassure you that you are free of cancer and need not pay close attention to early clinical signs or symptoms. For these reasons, physicians need to be careful when ordering and interpreting screening tests for cancer. This is also the reason that the same screening test should not be repeated to confirm the presence of the cancer it implicates.
    Because a diagnosis of cancer must always be made with as much certainty as possible, positive screening test results are insufficient for clinical decision making. A biopsy is required to definitively diagnose cancer. To learn more about how cancer is diagnosed, see the cancer diagnosis section of this classroom.
    When cancer is confirmed, staging tests are used to determine whether it has spread to other parts of the body. This information helps doctors choose the appropriate treatment approach for your cancer and to determine your prognosis. To learn more about how cancer is staged, see the cancer staging and grading section of this classroom.

    Genetic Testing

    Physicians use genetic tests to detect the presence of genetic mutations that may signal the presence or the risk of a disease or disorder. Genetic testing serves a number of purposes. For example, it has long been used to screen newborn children for genetic disorders. It also allows couples to determine the risk for passing on an inherited disorder to their children. To learn more about genetic mutations, see the cancer genetics section of Cancer 101.
    A more recent innovation for genetic testing is its use in estimating the lifetime risk of developing certain cancers in adults. For example, women who carry one of two BRCA gene mutations have an 85% risk of developing breast cancer during their lifetime. This compares to a lifetime risk of approximately 12% in the general population. However, since this mutation only accounts for about 5% of breast cancers, it is not an appropriate screening test for the vast majority of women. It is, however, an appropriate test for patients who have a strong family history of breast cancer.
    Despite the fact that more and more genetic screening tests for cancer risk are being developed and marketed, they are not without their controversy. Questions remain about who should have access to genetic information and how this information should be used. If you have a strong family history of cancer, you may wish to speak with your doctor about the risks of benefits of genetic screening.
    What are the signs and symptoms of cancer?How is cancer diagnosed?What is staging and grading?How is cancer treated?Can cancer be prevented?What are some other cancer resources I can use?


    American Cancer Society. Cancer Facts & Figures 2003 . Atlanta, GA: American Cancer Society, Inc; 2003.

    Bast RC, Kufe DW, Pollock RE, et al. Eds. Cancer Medicine . 5th ed. Hamilton, ON: Decker Inc; 2000.

    Cancer. Merck Manual of Medical Information website. Available at: http://www.merck.com/mrkshared/mmanual%5Fhome/contents.jsp . Accessed March 25, 2003.

    Detailed guide. American Cancer Society website. Available at: http://www.cancer.org/ . Accessed August 1, 2008.

    Finley RS, Balmer C. Concepts in Oncology Therapeutics . 2nd ed. Bethesda, MD: American Society of Health-System Pharmacists;1998.

    Fox SI. Human Physiology . 4th ed. Dubuque, IA: William C. Brown Publishers; 1993.

    Prostate cancer: early detection. American Cancer Society website. Available at: http://www.cancer.org/Cancer/ProstateCancer/MoreInformation/ProstateCancerEarlyDetection/prostate-cancer-early-detection-acs-recommendations . Updated February 27, 2012. Accessed March 20, 2012.

    Screening and testing. National Cancer Institute website. Available at: http://www.cancer.gov/cancertopics/screening . Accessed August 1, 2008.

    3/19/2012 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Screening for cervical cancer. US Preventive Services Task Force website. Available at: http://www.uspreventiveservicestaskforce.org/uspstf/uspscerv.htm . Published March 2012. Accessed March 19, 2012. Saslow D, Soloman D, Lawson H, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA: A Cancer Journal for Clinicians. 2012 Mar 14 early online.

    Revision Information

  • Can we help answer your questions?

    Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.